MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Crescent Biopharma (CBIO) Ownership - Who owns Crescent Biopharma?

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
498.28M
P/E Ratio
N/A
Total Cash
189.16M
Projected Growth
N/A
Total Debt
1.54M
Revenue
11.88M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.86
Total Debt/Equity
N/A
Revenue/Share
0.43 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CBIO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CBIO
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A